Dr. Reddy's Laboratories
RDY
#1699
Rank
NZ$20.54 B
Marketcap
NZ$24.56
Share price
0.35%
Change (1 day)
0.48%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : NZ$1.36 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has NZ$1.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31NZ$1.19 B-26.81%
2024-03-31NZ$1.63 B35.92%
2023-03-31NZ$1.20 B42.49%
2022-03-31NZ$0.84 B24.63%
2021-03-31NZ$0.67 B17.78%
2020-03-31NZ$0.57 B9.89%
2019-03-31NZ$0.52 B17.4%
2018-03-31NZ$0.44 B11.64%
2017-03-31NZ$0.39 B-54.25%
2016-03-31NZ$0.87 B1.95%
2015-03-31NZ$0.85 B32.68%
2014-03-31NZ$0.64 B32.55%
2013-03-31NZ$0.48 B11.76%
2012-03-31NZ$0.43 B155.21%
2011-03-31NZ$0.17 B-47.18%
2010-03-31NZ$0.32 B50.92%
2009-03-31NZ$0.21 B-43.43%
2008-03-31NZ$0.37 B-35.29%
2007-03-31NZ$0.58 B324%
2006-03-31NZ$0.13 B-55.61%
2005-03-31NZ$0.31 B29.66%
2004-03-31NZ$0.23 B-13.12%
2003-03-31NZ$0.27 B16.09%
2002-03-31NZ$0.23 B820.77%
2001-03-31NZ$25.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
NZ$25.93 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.81 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$7.69 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$16.88 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$18.09 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France